STAT3 and pulmonary arterial hypertension: Compared with scrambled siRNA (siSCRM), RAGE siRNA (siRAGE) significantly reduced STAT3 activation in both stimulated control cells and PAH‐PASMCs, restoring STAT3 activation at control levels (2‐fold decrease, P<0.05).